Skip to content

DBT-SFT Therapy for patients with ADHD and SUD

Dialectical Behavior- Schema Focused Therapy (DBT-SFT): a pilot study for the treatment of patients with Attention Deficit Hyperactivity Disorder (ADHD) and substance use disorders (SUD) - Dialectical Behavior- Schema Focused Therapy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON58536
Enrollment
32
Registered
2025-07-04
Start date
2023-09-26
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention Deficit Disorder, Substance Use Disorder, Impulsivity, personality disorders ADHD, substance use, impulsivity, personality disorders

Interventions

A 9-month group-based psychotherapy program combining elements of Dialectical Behavior and Schema Focused Therapy.

Sponsors

Radboud Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for participation in the treatment program are: men between the age of 18 – 65 years, ADHD (all subtypes) as classified in the DSM-5, SUD according to DSM-5, being in outpatient treatment, and written informed consent. As we chose an observational design from a real-life setting, there are no additional study inclusion criteria. We expect to have sufficient number of patients (N=32) for our analyses after finalization of four consecutive groups at the psychiatry department of the Radboud University Medical Center. Patient data will be collected from routine outcome measurements between 2023 and 2027.

Exclusion criteria

Exclusion criteria: Exclusion criteria for participation in the treatment program are the inability to participate due to cognitive impairments, psychotic symptoms and/or insufficient understanding of the Dutch language (clinical judgment). Patients that do not provide consent for the use of their clinical data will be allowed to participate in the program, but their data will be excluded from any scientific analyses.

Design outcomes

Primary

MeasureTime frame
The main study parameter during this 9-month ‘group-based DST’ program is the improvement of patients’ ADHD symptoms (measured with the ASRS) and substance use or craving (measured with the MATE and diary cards). 

Secondary

MeasureTime frame
Secondary parameters in this treatment program aimed to improve emotion regulation skills and hereby reduce (mal)adaptive schemas and modes (measured with the YSQ, SMI and diary cards) and improve functional outcomes (measured with the WHODAS). 

Countries

Netherlands

Contacts

Public ContactE.L. Noordraven

Radboud Universitair Medisch Centrum

Ernst.Noordraven@radboudumc.nl0650019798

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: May 1, 2026